Research Centre for Medical Genetics
115522, Moscow,
Moskvorechye st., 1
+7 (495) 111-03-03
Mo-Fr: 9:00 - 17:00

Participation in the International Webinar on the Management of Cystic Fibrosis Patients in COVID-19

On April 16, 2020, an International Webinar on the Management of Cystic Fibrosis Patients in COVID-19 was held. The teleconference brought together cystic fibrosis experts from all over the world.

The FSBI RCMG Genetic Epidemiology Laboratory researchers (Head is Prof. R. Zinchenko)  Professor N. Kashirskaya, Doctor of medical science, and N.V. Petrova, Doctor of biological science, as well as physicians of the Cystic Fibrosis Research and Clinical Department (Head is Prof. E.I. Kondratyeva) attended the webinar.

Professors FrancescoBlasi (Milan, Italy) and PeterWark (New South, Australia), as well as Dr. Pedro Mondejar (Murcia, Spain) shared their experience in identifying and treating patients with cystic fibrosis and with COVID-19, talked about preventive measures aimed at reducing risk of contamination of both the patients and specialists working with them during the COVID-19 pandemic. Most of the information presented based on the speakers’ experience, given the limited amount of data analyzed.

Patients with cystic fibrosis rarely become contaminated with COVID-19, and if this happens, the disease proceeds without any serious complications and rarely requires hospitalization. Such relatively favorable course of coronavirus infection in patients with cystic fibrosis is associated with many factors, including the young age of the patients, their early isolation and transition to remote counseling by specialists of the CF centers, azithromycin long-term administration by patients with chronic Pseudomonas infection, and even with competition between bacteria and viruses per host body. The main risk group for the adverse outcome of COVID-19 are CF patients who have undergone transplantation and are receiving immunosuppressive therapy.

438 people from 30 countries, including 43 doctors from Russia, have listened to a series of lectures by leading experts in the treatment of cystic fibrosis patients.

The audience had the opportunity to ask questions using the chat function.